STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported fourth-quarter net income of $7 million, after reporting a loss in the same period a year earlier.

The Stoughton, Massachusetts-based company said it had profit of 20 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 29 cents per share.

The specialty pharmaceutical company posted revenue of $76.3 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $76.8 million.

For the year, the company reported net income of $26.8 million, or 76 cents per share, swinging to a profit in the period. Revenue was reported as $310 million.

Collegium Pharmaceutical shares have increased 30% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $26.03, a rise of 13% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News